Clinical trials

Condition   Drug Name  
Study Adalimumab in arthritis
Design Pooled/meta-analysis
Patients 13060
Treatment Regimen Adalimumab
Conclusions An analysis of the clinical trial database found consistent safety accross indications and a possible reduction in mortality in rheumatoid arthritis patients
Reference(s) Adalimumab clinical trial safety in multiple indications and reduced mortality in rheumatoid arthritis
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1111.
Author and Affiliation Burmester, G., Mease, P., Dijkmans, B., Gordon, K., Lovell, D., Kent, J., Pangan, A.